Evidence map›Paper›PMID 28360207›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2017

Milan Grkovski, Sally-Ann Emmas, Sean D Carlin

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Prospective Evaluation of a Tumor Control Probability Model Based on DynamicJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Trial
  2. Monitoring early response to chemoradiotherapy withEuropean journal of nuclear medicine and molecular imaging · 2017
    Trial
  3. Article
  4. A comparison study of dynamic [Journal of cancer research and clinical oncology · 2024
    Article
  5. Article
  6. Glioblastoma PET/MRI: kinetic investigation of [European journal of nuclear medicine and molecular imaging · 2023
    Article
  7. Influence of the scan time point when assessing hypoxia inEuropean journal of nuclear medicine and molecular imaging · 2020
    Article
  8. Review
  9. PARP inhibitor combinations in prostate cancer.Therapeutic advances in medical oncology · 2020
    Review
  10. The Roles of Hypoxia Imaging UsingJournal of clinical medicine · 2019
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 3 countries.

Milan GrkovskiDepartment of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
Sally-Ann EmmasImaging Team, Personalised Healthcare and Biomarkers, AstraZeneca, Macclesfield, United Kingdom; and.
Sean D CarlinDepartment of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York carlins@mail.med.upenn.edu.
Memorial Sloan Kettering Cancer Center · USAstraZeneca (United Kingdom) · GB

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

Multiparametric imaging of tumor perfusion and hypoxia with dynamic

Indexed as

Models, BiologicalAngiogenesis InhibitorsAnimalsBlood CirculationCell Transformation, NeoplasticColorectal NeoplasmsFemaleHT29 CellsHumansIndolesKineticsMisonidazolePositron-Emission TomographyQuinazolinesRatsTumor HypoxiaAngiogenesis InhibitorscediranibfluoromisonidazoleIndolesMisonidazoleQuinazolines18F-FMISOantiangiogenesiscediranibhypoxiakinetic modelingperfusion

Identifiers

PMID28360207
PMCPMC5632735
OpenAlexW2599407274

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.